Latest
Swiss market slides as Novartis falls on failed drug trial, dollar weakens against franc
The SMI dropped over 1% to 14,221 points, led by a 3% slide in Novartis after negative Pelacarsen news, while the U.S. dollar fell to 80.89 rappen.
DAX slips below 26,000 points as rate outlook and oil prices tighten
The German benchmark index fell 0.37% to 25,951, breaking the 26,000 level amid ECB rate‑hike expectations, US inflation data and Brent crude trading above $97.
Swiss SMI slides over 1% as Novartis tumbles on failed drug trial
SMI fell 1.2% to 14,221 points, led by a 4.2% drop in Novartis after its Pelacarsen trial missed; other health‑care stocks and Schindler also fell, while Kühne+Nagel and ABB posted modest gains.
FINMA director stresses proportional oversight for Swiss banks
FINMA says supervision intensity follows size, complexity and risk, not a blanket approach on small banks, citing inspection frequency and the 2020 Kleinbankenregime.
DAX slips below 26,000 as oil prices stay high and markets await ECB decision
The German benchmark index fell 0.24% to 25,983 points, while the MDAX rose 0.23% to 32,429. Brent crude hovered just under $97 a barrel and the ECB is set to raise rates to 2.5% on Thursday.
Swiss equities slip as Roche, Novartis drag; ABB gains, yen hits 7‑month high
The SMI fell about 1% to 14,221 points, led by 3%‑plus losses in Novartis and Roche after a failed Pelacarsen trial. ABB rose, while the yen strengthened to 154.07 per dollar, its lowest level in seven months.
Germany to Deploy Anti‑Sabotage Shield After Failed Drone Attack
Interior Minister Alexander Dobrindt announced a package of police, cyber and AI measures to protect airports, transport hubs and critical infrastructure from drone and sabotage threats.
Europe's sovereign yields diverge as France and Germany face higher deficits
Ten‑year bond yields in France and Germany are nearing 2007 highs, while Spain and Italy remain below 2023 peaks, reflecting differing fiscal outlooks across the euro area.
Swiss SMI edges up 0.2% as Logitech and Roche lead gains, Richemont and Nestlé fall
The Swiss Market Index closed at 14,394 points, up 0.22%, driven by Logitech (+3.3%) and Roche (+2.1%). Luxury stocks lagged, while US software shares surged on Snowflake’s outlook.
Swiss stocks rise as Roche leads; Richemont falls on luxury sector weakness
Swiss Market Index edges up 0.12% as Roche gains on licensing deal, while Richemont drops 2.4% amid broader luxury sector decline. Swiss franc strengthens to 0.9384 per euro after August inflation surprise.
Swiss franc strengthens after higher-than-expected Swiss inflation data
The Swiss franc surged after August inflation rose to a two-year high, while the euro and dollar weakened. Analysts see potential SNB tightening in December, though energy-driven price gains may limit immediate action.
US stocks rise on Fed rate pause hopes; Swiss franc strengthens
Wall Street advances as investors bet on a September Fed pause, while the Swiss franc gains after higher-than-expected Swiss inflation. SMI mixed as Nestlé weighs on index.
Zumtobel Q1 FY2026/27 margins rise on cost cuts despite flat revenue
Austrian lighting group Zumtobel posted a 25% rise in adjusted EBIT to €8.2 million in Q1 FY2026/27, even as revenue slipped 0.9% to €264.1 million. Guidance maintained for flat annual sales.
Swiss stocks rise on US gains; Nestlé, Richemont drag; franc strengthens
Swiss Market Index edges up 0.2% after early 0.5% gain as Nestlé drags; Roche and Logitech lead gains. Euro falls to 0.9384 francs as Swiss inflation surprises.
US stocks rise on softer yields; Swiss franc strengthens after inflation surprise
U.S. benchmarks advance 0.4-0.6% at open as Treasury yields ease; SMI up 0.5% led by Roche and Logitech. Swiss inflation hits two-year high, lifting franc to 0.9392 per euro.
UBS identifies four European investment themes as earnings rebound gains traction
Strategists flag industrials, banks, quality leaders and Swiss mid-caps as Europe’s earnings cycle shifts from stagnation to growth, with 15% EPS growth forecast for 2026.
US stocks set for modest gain; SMI rises on Roche, Logitech gains; Swiss franc strengthens
U.S. futures point to a modestly higher open as Middle East tensions ease slightly. Swiss Market Index climbs 0.2% on Roche and Logitech gains, while the franc strengthens after Swiss inflation surprises.
US stocks cautious as oil prices rise; Swiss franc strengthens on inflation data
Dow Jones and Nasdaq futures show muted gains ahead of key U.S. jobs data, while rising oil prices and geopolitical tensions curb risk appetite. Swiss franc surges to 0.9392 per euro after unexpected inflation jump.
Swiss inflation hits two-year high, SNB rate hike odds rise
August CPI surge to 0.8% exceeds forecasts, lifting expectations for a potential Swiss National Bank rate increase by late 2027. Energy prices drive the jump while core inflation remains subdued.
Swiss stocks steady as SMI faces direction; Nestlé weighs, Swatch falls; franc strengthens
Swiss market opens flat with Nestlé down 0.67% while Swatch drops 2.3%; franc gains to 0.9392 per euro and 0.8092 per dollar after August inflation hits 0.8%.
Global bond rout pauses as European, Aussie yields retreat from peaks
German and Australian 10-year yields fall from multi-year highs after a week of aggressive selling, while U.S. labor data tempers rate-hike bets ahead of ECB meeting.
Eurozone business activity steady in August as services slow
Eurozone composite PMI held at 52.0 in August, matching July’s eight-month high, while services activity slipped to a two-month low. Germany led regional growth, France remained in contraction.
DAX edges up 0.05% as oil prices ease after Iran tensions
German blue-chip index recovers fractionally after three days of losses as Brent crude slips below $100. Broader Euro Stoxx 50 slips 0.05% amid cautious regional sentiment.
Swiss office real estate resilient amid AI disruption risks
Raiffeisen study finds structural shifts in demand, with KI exposure and flexible work policies limiting office space cuts despite pandemic-era shifts. Leerage rates remain below pre-COVID levels.